Scaling the production of biomaterials is a complex yet rewarding endeavour. Moving from the lab to the pilot stage involves addressing multiple interconnected challenges:
- Raw Material Requirements: Sourcing inputs that meet scalability needs while maintaining quality and sustainability.
- Operational Complexities: Managing utilities, logistics, and other operational factors on a larger scale.
- Process Refinement: Small formulation issues in the lab can become magnified at scale, requiring careful optimisation.
These challenges underscore the importance of collaboration and support from industry and investors. With the right resources and partnerships, the transition from lab to market can unlock enormous positive potential for biomaterials.